Title |
Systematic comparison of monoclonal versus polyclonal antibodies for mapping histone modifications by ChIP-seq
|
---|---|
Published in |
Epigenetics & Chromatin, November 2016
|
DOI | 10.1186/s13072-016-0100-6 |
Pubmed ID | |
Authors |
Michele Busby, Catherine Xue, Catherine Li, Yossi Farjoun, Elizabeth Gienger, Ido Yofe, Adrianne Gladden, Charles B. Epstein, Evan M. Cornett, Scott B. Rothbart, Chad Nusbaum, Alon Goren |
Abstract |
The robustness of ChIP-seq datasets is highly dependent upon the antibodies used. Currently, polyclonal antibodies are the standard despite several limitations: They are non-renewable, vary in performance between lots and need to be validated with each new lot. In contrast, monoclonal antibody lots are renewable and provide consistent performance. To increase ChIP-seq standardization, we investigated whether monoclonal antibodies could replace polyclonal antibodies. We compared monoclonal antibodies that target five key histone modifications (H3K4me1, H3K4me3, H3K9me3, H3K27ac and H3K27me3) to their polyclonal counterparts in both human and mouse cells. Overall performance was highly similar for four monoclonal/polyclonal pairs, including when we used two distinct lots of the same monoclonal antibody. In contrast, the binding patterns for H3K27ac differed substantially between polyclonal and monoclonal antibodies. However, this was most likely due to the distinct immunogen used rather than the clonality of the antibody. Altogether, we found that monoclonal antibodies as a class perform equivalently to polyclonal antibodies for the detection of histone post-translational modifications in both human and mouse. Accordingly, we recommend the use of monoclonal antibodies in ChIP-seq experiments. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 21 | 45% |
United Kingdom | 4 | 9% |
Canada | 3 | 6% |
Germany | 2 | 4% |
Switzerland | 1 | 2% |
Sweden | 1 | 2% |
Italy | 1 | 2% |
France | 1 | 2% |
Australia | 1 | 2% |
Other | 0 | 0% |
Unknown | 12 | 26% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 26 | 55% |
Members of the public | 21 | 45% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Sweden | 1 | 1% |
Italy | 1 | 1% |
Switzerland | 1 | 1% |
Unknown | 73 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 18 | 24% |
Student > Bachelor | 13 | 17% |
Researcher | 12 | 16% |
Student > Doctoral Student | 5 | 7% |
Student > Master | 5 | 7% |
Other | 6 | 8% |
Unknown | 17 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 28 | 37% |
Agricultural and Biological Sciences | 15 | 20% |
Medicine and Dentistry | 3 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Chemistry | 2 | 3% |
Other | 8 | 11% |
Unknown | 18 | 24% |